References
- Bijkerk H. Surveillance and control of poliomyelitis in the Netherlands. Rev Inf Dis 1984; 6: 451–6.
- Rümke HC, Oostvogel PM, Van Steenis G, Van Loon AM. Poliomyelitis in the Netherlands. Population immunity and exposure between two epidemics in 1979 and 1981. Epidemiology and Infection 1995; 115: 289–98.
- Böttiger M. Polio immunity to killed vaccine: an 18-year follow-up. Vaccine 1990; 8: 443–5.
- Oostvogel PM, Van Wijngaarden JK, Van der Avoort HGAM, Mulders MN, Conyn-van Spaendonck MAE, Rümke HC, Van Steenis G, Van Loon AM. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992–93. Lancet 1994; 344: 665–70.
- Van Wezel AL, Van Steenis G, Hannik CA, Cohen H. New approach to the production of concentrated and purified inactivated polio and rabies tissue culture vaccines. Dev Biol Stand 1978; 41: 159–68.
- Montagnon BJ. Polio and rabies virus vaccines produced in continuous cell lines: a reality for Vero cell line. Dev Biol Stand 1989; 70: 27–47.
- Vidor E, Meschievitz C, Plotkin S. Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine. Pediatr Infect Dis J 1997; 16: 312–22.
- Albrecht P, Van Steenis G, Van Wezel AL, Salk J. Standardization of poliovirus neutralising antibody tests. Rev Infect Dis 1984; 6: 540–6.
- Dean AG, Dean JA, Coulombier D, Brendel KA, Smith DC, Burton AH, Dicker RC, Sullivan K, Fagan RF, Arner TG. Epi Info, version 6: a word processing, database, and statistics program for epidemiology on microcomputers. Atlanta: Centers for Disease Control and Prevention, 1994.
- Salk J, Cohen H, Fillastre C, Stoeckel P, Rey JL, Schlumberger M, Nicholas DD, Van Steenis G, Van Wezel AL, Triau R, Saliou P, Barry LF, Moreau JP, Merieux C. Killed poliovirus antigen titrations in humans. Dev Biol Stand 1978; 41: 119–32.
- Salk J, Stoeckel P, Van Wezel AL, Lapinleimu K, Van Steenis G. Antigen content of inactivated poliovirus vaccine for use in a one or twodose regimen. Annals of Clinical Research 1982; 14: 204–12.
- Stoeckel P, Schlumberger M, Parent G, Maire B, Van Wezel AL, Van Steenis G, Salk D. Use of killed poliovirus vaccine in a routine immunization program in West Africa. Rev Infect Dis 1984; 6: 4636.
- Cohen H, Nagel J. Two injections of Diphtheria Tetanus Pertussis Polio vaccine as the backbone of a simplified immunization schedule in developing countries. Rev Infect Dis 1984; 6: 3501.
- Rümke HC, Schlumberger M, Floury B, Nagel J, Van Steenis G. Serological evaluation of a simplified immunization schedule using quadruple DPTpolio vaccine in Burkina Faso. Vaccine 1993; 11: 1113–8.
- Simasathien S, Migasena S, Beuvery C, Van Steenis G, Samakoses R, Pitisuttitham P, Vesikari T. Comparison of enhanced potency inactivated poliovirus vaccine (EIPV) versus standard oral poliovirus vaccine (OPV) in Thai infants. Scand J Infect Dis 1994; 26: 731–8.
- Kok PW, Leeuwenburg J, Tukei P, Van Wezel AL, Kapsenberg JG, Van Steenis G, Galazka A, Robertson SE, Robinson D. Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. Bull WHO 1992; 70: 93–103.
- Stratton KR, Howe CJ, Johnston RB Jr. Vaccine safety committee; Division of Health Promotion and disease prevention, Institute of Medicine. Adverse events associated with childhood vaccines. Evidence bearing on causality. Washington DC: National Academic Press, 1994: 70–2.